Financhill
Buy
67

SURYY Quote, Financials, Valuation and Earnings

Last price:
$22.80
Seasonality move :
10.46%
Day range:
$22.80 - $22.80
52-week range:
$14.83 - $24.38
Dividend yield:
0%
P/E ratio:
15.81x
P/S ratio:
3.16x
P/B ratio:
1.36x
Volume:
8
Avg. volume:
159
1-year change:
34.67%
Market cap:
$21.3B
Revenue:
$6.7B
EPS (TTM):
$1.44

Earnings Data

Next earnings date for SURYY
Feb 05
2026
Most recent earnings per share
$0.32
Beat by $0.32
(Nov 11/2025)
Consensus Estimate
--
(Nov 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SURYY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/11/2025 Q3 -- $1.6B $0.32 -- --
06/30/2025 Q2 -- $2B $0.55 -- --
03/31/2025 Q1 -- $1.5B $0.31 -- --
02/13/2025 Q4 -- $1.6B $0.26 -- --
09/30/2024 Q3 -- $1.5B $0.25 -- --
06/30/2024 Q2 -- $2B $0.50 -- --
06/24/2024 Q1 -- $1.6B $0.22 -- --
02/13/2024 Q4 -- $1.5B $0.28 -- --
11/13/2023 Q3 -- -- $0.36 -- --
06/30/2023 Q2 -- -- $0.44 -- --
03/31/2023 Q1 -- -- $0.21 -- --
12/31/2022 Q4 -- -- $0.31 -- --
09/30/2022 Q3 -- -- $0.31 -- --
06/30/2022 Q2 -- -- $0.43 -- --
03/31/2022 Q1 -- -- $0.19 -- --
12/31/2021 Q4 -- -- $0.35 -- --
09/30/2021 Q3 -- -- $0.40 -- --
06/30/2021 Q2 -- -- $0.47 -- --
03/31/2021 Q1 -- -- $0.13 -- --
12/31/2020 Q4 -- -- $0.32 -- --
09/30/2020 Q3 -- -- $0.31 -- --
06/30/2020 Q2 -- -- $0.64 -- --
03/31/2020 Q1 -- -- $0.27 -- --
12/31/2019 Q4 -- -- $0.19 -- --
09/30/2019 Q3 -- -- $0.37 -- --
06/30/2019 Q2 -- -- $0.54 -- --
03/31/2019 Q1 -- -- $0.30 -- --
12/31/2018 Q4 -- -- $0.18 -- --
09/30/2018 Q3 -- -- $0.29 -- --
06/30/2018 Q2 -- -- $0.47 -- --
03/31/2018 Q1 -- -- $0.11 -- --
12/31/2017 Q4 -- -- $0.32 -- --
09/30/2017 Q3 -- -- $0.30 -- --
06/30/2017 Q2 -- -- $0.41 -- --
03/31/2017 Q1 -- -- $0.14 -- --
12/31/2016 Q4 -- -- $0.28 -- --
09/30/2016 Q3 -- -- $0.27 -- --
06/30/2016 Q2 -- -- $0.32 -- --
03/31/2016 Q1 -- -- $0.14 -- --
12/31/2015 Q4 -- -- $0.22 -- --

Sumitomo Realty & Development Co., Ltd. Earnings Questions

  • How Much did Sumitomo Realty & Development Co., Ltd. Generate in Revenue Last Quarter?

    Sumitomo Realty & Development Co., Ltd. reported $1.6B worth of top line sales in its most recent quarter.

  • Did Sumitomo Realty & Development Co., Ltd. Beat Earnings Last Quarter?

    Sumitomo Realty & Development Co., Ltd. announced earnings per share of $0.32 which represents a beat of analyst forecast a -- per share.

  • Is Sumitomo Realty & Development Co., Ltd. Profitable?

    Sumitomo Realty & Development Co., Ltd. reported $596.6M that represents $0.64 per share over the last quarter.

  • What is the Analyst Consensus for Sumitomo Realty & Development Co., Ltd. EPS Next Year?

    Sumitomo Realty & Development Co., Ltd.'s earnings are forecast to grow from $1.33 per share to -- per share next year representing an increase of --.

  • When is Sumitomo Realty & Development Co., Ltd.'s Earnings Date?

    Sumitomo Realty & Development Co., Ltd.'s next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock